Efficacy, Safety, and Dose-Response Characteristics of Glipizide Gastrointestinal Therapeutic System on Glycemic Control and
Insulin Secretion in NIDDM: Results of two multicenter, randomized, placebo-controlled clinical trials Diabetes Care April 1997 20:597-606; doi:10.2337/diacare.20.4.597